Gerhard Rammes Selected Research

neramexane

5/2009	Neramexane: a moderate-affinity NMDA receptor channel blocker: new prospects and indications.
2/2006	Neramexane (merz pharmaceuticals/forest laboratories).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerhard Rammes Research Topics

Disease

16	Alzheimer Disease (Alzheimer's Disease) 05/2022 - 02/2006
6	Cognitive Dysfunction 01/2022 - 09/2011
5	Pain (Aches) 02/2009 - 11/2004
4	Mental Disorders (Mental Disorder) 03/2022 - 12/2010
3	Amyloid Plaque 07/2022 - 01/2019
3	Anxiety Disorders (Anxiety Disorder) 03/2022 - 01/2012
3	Chronic Pain 01/2019 - 11/2004
2	Major Depressive Disorder (Major Depressive Disorders) 03/2022 - 01/2016
2	Necrosis 01/2020 - 01/2017
2	Huntington Disease (Huntington's Disease) 01/2019 - 05/2009
2	Seizures (Absence Seizure) 11/2017 - 03/2014
2	Neuralgia (Stump Neuralgia) 01/2016 - 08/2005
2	Postoperative Cognitive Complications 01/2013 - 12/2009
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2012 - 07/2009
2	Alcoholism (Alcohol Abuse) 02/2006 - 05/2002
1	Postpartum Depression (Post-Natal Depression) 03/2022
1	Neuroinflammatory Diseases 03/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Amnesia (Dissociative Amnesia) 01/2022
1	Unconsciousness (Loss of Consciousness) 01/2017
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2016
1	Type 2 Diabetes Mellitus (MODY) 10/2015
1	Macular Degeneration (Age-Related Maculopathy) 05/2015
1	Glaucoma 05/2015
1	Wounds and Injuries (Trauma) 03/2014
1	Memory Disorders (Memory Loss) 05/2011
1	Gliosis 12/2010
1	Encephalitis (Encephalitis, Rasmussen) 12/2010
1	Panic Disorder (Panic Attack) 07/2009
1	Parkinson Disease (Parkinson's Disease) 05/2009
1	Substance-Related Disorders (Drug Abuse) 05/2009
1	Dementia (Dementias) 05/2009
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 05/2009
1	Down Syndrome (Down's Syndrome) 05/2009
1	Central Nervous System Diseases (CNS Diseases) 02/2006
1	Neuroblastoma 11/2005
1	Multiple Sclerosis 08/2005
1	Tremor (Tremors) 08/2005

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 03/2022 - 11/2005
6	Amyloid (Amyloid Fibrils)IBA 05/2022 - 10/2015
5	Amyloid beta-PeptidesIBA 01/2019 - 05/2011
5	Pharmaceutical PreparationsIBA 01/2018 - 02/2006
4	LigandsIBA 03/2022 - 07/2009
3	gamma-Aminobutyric Acid (GABA)IBA 03/2022 - 07/2009
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2017 - 11/2004
2	NeurosteroidsIBA 03/2022 - 01/2012
2	Hypnotics and Sedatives (Sedatives)IBA 01/2022 - 01/2012
2	BenzodiazepinesIBA 01/2022 - 07/2009
2	Isoflurane FDA LinkGeneric 01/2021 - 10/2013
2	Anesthetics (Anesthetic Agents)IBA 01/2021 - 01/2017
2	Caspase 3 (Caspase-3)IBA 01/2020 - 01/2017
2	Tranexamic Acid (AMCA)FDA Link 11/2017 - 03/2014
2	N-Methylaspartate (NMDA)IBA 09/2017 - 02/2006
2	Peptides (Polypeptides)IBA 05/2017 - 10/2015
2	Antidepressive Agents (Antidepressants)IBA 01/2016 - 11/2005
2	Corticotropin-Releasing HormoneIBA 01/2013 - 09/2011
2	Anti-Anxiety Agents (Anxiolytics)IBA 01/2012 - 07/2009
2	Memantine (Namenda)FDA Link 02/2010 - 05/2009
2	neramexaneIBA 05/2009 - 02/2006
2	Neuroprotective AgentsIBA 05/2009 - 02/2006
1	Complement System Proteins (Complement)IBA 07/2022
1	Immunologic Factors (Immunomodulators)IBA 03/2022
1	Pregnanolone (Allopregnanolone)IBA 03/2022
1	brexanoloneIBA 03/2022
1	zuranoloneIBA 03/2022
1	Diazepam (Valium)FDA LinkGeneric 01/2022
1	Midazolam (Versed)FDA LinkGeneric 01/2022
1	General AnestheticsIBA 01/2021
1	Sevoflurane (Ultane)FDA LinkGeneric 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2020
1	Sigma-1 ReceptorIBA 01/2019
1	pridopidineIBA 01/2019
1	EnzymesIBA 01/2018
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 11/2017
1	Glutamic Acid (Glutamate)FDA Link 11/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Desipramine (Pertofrane)FDA LinkGeneric 01/2016
1	DipeptidesIBA 05/2015
1	Tryptophan (L-Tryptophan)FDA Link 05/2015
1	2- (2- amino- 3- (1H- indol- 3- yl)propionylamino)- 2- methylpropionic acidIBA 05/2015
1	AcidsIBA 05/2015
1	Aminobutyrates (Aminobutyric Acid)IBA 03/2014
1	Hormones (Hormone)IBA 09/2011
1	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 09/2011
1	Biomarkers (Surrogate Marker)IBA 12/2010
1	N- benzyl- N- ethyl- 2- (7,8- dihydro- 7- methyl- 8- oxo- 2- phenyl- 9H- purin- 9- yl)acetamideIBA 07/2009
1	Opioid Analgesics (Opioids)IBA 02/2009
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 02/2009
1	TRPV1 receptorIBA 01/2007
1	Serotonin (5 Hydroxytryptamine)IBA 11/2005
1	Antipsychotic Agents (Antipsychotics)IBA 11/2005
1	CationsIBA 11/2005
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 11/2005
1	Sucrose (Saccharose)IBA 11/2005
1	Analgesics (Analgesic Drugs)IBA 08/2005
1	CannabinoidsIBA 08/2005
1	EndocannabinoidsIBA 08/2005

Therapy/Procedure

3	Anesthesia 01/2019 - 12/2009
1	Topical Administration 05/2015